0139 GMT - Ansell's change of chief executive is the main risk for investors in the personal protective equipment manufacturer, UBS analyst David Low says. He thinks the Australia-listed company has largely banked the benefits of its 2024 acquisition of Kimberly-Clark's PPE business and productivity drive, and says he "will be looking for evidence of a credible pathway to sustained organic growth." Ansell has struggled to deliver on this in recent years, he adds. Low says that the stock looks to have valuation support but limited near-term catalysts. He awaits greater clarity on strategic priorities under CEO Nathalie Ahlstrom. UBS trims its target price by 1.1% to A$35.60 and maintains a neutral rating on the stock, which is down 0.2% at A$32.41. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
February 16, 2026 20:39 ET (01:39 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.